1. Home
  2. ELME vs NYXH Comparison

ELME vs NYXH Comparison

Compare ELME & NYXH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Elme Communities

ELME

Elme Communities

N/A

Current Price

$2.15

Market Cap

198.2M

Sector

Real Estate

ML Signal

N/A

Logo Nyxoah SA

NYXH

Nyxoah SA

N/A

Current Price

$3.48

Market Cap

190.6M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
ELME
NYXH
Founded
1960
2009
Country
United States
Belgium
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Medical/Dental Instruments
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
198.2M
190.6M
IPO Year
1994
2021

Fundamental Metrics

Financial Performance
Metric
ELME
NYXH
Price
$2.15
$3.48
Analyst Decision
Hold
Strong Buy
Analyst Count
3
3
Target Price
$12.67
$11.67
AVG Volume (30 Days)
1.1M
55.0K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
33.65%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$206,360,000.00
N/A
Revenue This Year
N/A
$97.32
Revenue Next Year
N/A
$241.74
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.10
$3.39
52 Week High
$17.68
$11.87

Technical Indicators

Market Signals
Indicator
ELME
NYXH
Relative Strength Index (RSI) 13.48 32.51
Support Level $2.10 N/A
Resistance Level $2.26 $5.02
Average True Range (ATR) 0.03 0.26
MACD 0.24 -0.08
Stochastic Oscillator 39.94 6.74

Price Performance

Historical Comparison
ELME
NYXH

About ELME Elme Communities

Elme Communities is a real estate investment trust engaged in owning and operating properties in the greater Washington DC metropolitan area. The company's real estate portfolio is comprised of office, retail, and multifamily properties located near transportation nodes. Washington REIT derives nearly all of its income in the form of rental revenue from tenants organized into long-term leases. The company's office assets contribute the majority of this income, while the rest is split fairly evenly between its retail and multifamily locations. Washington REIT's tenants are banking, consulting, law, and financial services firms.

About NYXH Nyxoah SA

Nyxoah SA is a health-technology company focused on the development and commercialization of solutions and services to treat sleep-disordered breathing conditions. The company's solution platform is based on the Genio system, a CE-Mark validated, user-centered, bilateral neurostimulation therapy to treat moderate to severe Obstructive Sleep Apnea (OSA), the common sleep disordered breathing condition that is associated with increased mortality risk and comorbidities including cardiovascular diseases, depression and stroke.

Share on Social Networks: